CTMC / A joint venture between Resilience and MD Anderson Cancer Center Revenue and Competitors

0, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CTMC / A joint venture between Resilience and MD Anderson Cancer Center's estimated annual revenue is currently $15.7M per year.(i)
  • CTMC / A joint venture between Resilience and MD Anderson Cancer Center's estimated revenue per employee is $155,000

Employee Data

  • CTMC / A joint venture between Resilience and MD Anderson Cancer Center has 101 Employees.(i)
  • CTMC / A joint venture between Resilience and MD Anderson Cancer Center grew their employee count by 16% last year.

CTMC / A joint venture between Resilience and MD Anderson Cancer Center's People

NameTitleEmail/Phone
1
Head Technical OperationsReveal Email/Phone
2
Head Regulatory AffairsReveal Email/Phone
3
Director, Cell Therapy Process DevelopmentReveal Email/Phone
4
Associate Director, Biologics Quality Assurance SystemsReveal Email/Phone
5
Associate Director, HR and Business OperationsReveal Email/Phone
6
Senior Manager Process DevelopmentReveal Email/Phone
7
Manager, Talent Acquisition & DevelopmentReveal Email/Phone
8
Senior Manager, Materials ManagementReveal Email/Phone
9
Senior Manager, CTMC Technical OperationsReveal Email/Phone
10
Senior Manager, Information TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M1344%N/AN/A
#2
$14.9M73-8%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M5-37%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M5131%N/AN/A
#8
$0.8M525%N/AN/A
#9
$1.6M913%N/AN/A
#10
$16.3M80-9%N/AN/A
Add Company

What Is CTMC / A joint venture between Resilience and MD Anderson Cancer Center?

Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.

keywords:N/A

N/A

Total Funding

101

Number of Employees

$15.7M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$45.8M101-22%N/A
#2
$22.2M101-1%N/A
#3
$32.8M101N/AN/A
#4
$14.6M101N/AN/A
#5
$15M10120%N/A